Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity ; volume:7 ; number:1 ; day:8 ; month:11 ; year:2004 ; pages:1-11 ; date:2.2004
Breast cancer research ; 7, Heft 1 (8.11.2004), 1-11, 2.2004
- Urheber
-
Cestac, Philippe
- Beteiligte Personen und Organisationen
-
Sarrabayrouse, Guillaume
Médale-Giamarchi, Claire
Rochaix, Philippe
Balaguer, Patrick
Favre, Gilles
Faye, Jean-Charles
Doisneau-Sixou, Sophie
SpringerLink (Online service)
- DOI
-
10.1186/bcr956
- URN
-
urn:nbn:de:1111-2016032355816
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cestac, Philippe
- Sarrabayrouse, Guillaume
- Médale-Giamarchi, Claire
- Rochaix, Philippe
- Balaguer, Patrick
- Favre, Gilles
- Faye, Jean-Charles
- Doisneau-Sixou, Sophie
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Novel Dual Antibody Staining Assay to Measure Estrogen Receptor Transcriptional Activity
Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator
Development of an orthogonal ligand-receptor pair based on synthetic estrogen analogs and engineered estrogen receptor for transcriptional regulation
Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program
Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Estrogen rescues heart failure through estrogen receptor Beta activation
Non-coding single nucleotide variants affecting estrogen receptor binding and activity
Chemical space, diversity and activity landscape analysis of estrogen receptor binders
Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-κB transcriptional activity in models of rheumatoid arthritis
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer
A Novel Dual Antibody Staining Assay to Measure Estrogen Receptor Transcriptional Activity
Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator
Development of an orthogonal ligand-receptor pair based on synthetic estrogen analogs and engineered estrogen receptor for transcriptional regulation
Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program
Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Estrogen rescues heart failure through estrogen receptor Beta activation
Non-coding single nucleotide variants affecting estrogen receptor binding and activity
Chemical space, diversity and activity landscape analysis of estrogen receptor binders
Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-κB transcriptional activity in models of rheumatoid arthritis
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer
A Novel Dual Antibody Staining Assay to Measure Estrogen Receptor Transcriptional Activity
Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator
Development of an orthogonal ligand-receptor pair based on synthetic estrogen analogs and engineered estrogen receptor for transcriptional regulation
Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program
Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Estrogen rescues heart failure through estrogen receptor Beta activation
Non-coding single nucleotide variants affecting estrogen receptor binding and activity
Chemical space, diversity and activity landscape analysis of estrogen receptor binders
Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-κB transcriptional activity in models of rheumatoid arthritis